MA30139B1 - Preparation de gamma-aminoacides ayant une affinite pour la proteine alpha-2-delta. - Google Patents

Preparation de gamma-aminoacides ayant une affinite pour la proteine alpha-2-delta.

Info

Publication number
MA30139B1
MA30139B1 MA31065A MA31065A MA30139B1 MA 30139 B1 MA30139 B1 MA 30139B1 MA 31065 A MA31065 A MA 31065A MA 31065 A MA31065 A MA 31065A MA 30139 B1 MA30139 B1 MA 30139B1
Authority
MA
Morocco
Prior art keywords
delta
preparation
gamma
affinity
aminoacids
Prior art date
Application number
MA31065A
Other languages
English (en)
Inventor
Margaret Claire Evans
Llyod Charles Franklin
Lorraine Michelle Murtagh
Thomas Norman Nanninga
Bruce Allen Pearlman
James Edward Saenz
Niamh Josephine Willis
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of MA30139B1 publication Critical patent/MA30139B1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/30—Preparation of optical isomers
    • C07C227/32—Preparation of optical isomers by stereospecific synthesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/04—Formation of amino groups in compounds containing carboxyl groups
    • C07C227/06—Formation of amino groups in compounds containing carboxyl groups by addition or substitution reactions, without increasing the number of carbon atoms in the carbon skeleton of the acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
    • C07C229/08—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to hydrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C253/00—Preparation of carboxylic acid nitriles
    • C07C253/30—Preparation of carboxylic acid nitriles by reactions not involving the formation of cyano groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/19—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and carboxyl groups, other than cyano groups, bound to the same saturated acyclic carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00—Preparation of nitrogen-containing organic compounds
    • C12P13/002—Nitriles (-CN)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00—Preparation of nitrogen-containing organic compounds
    • C12P13/005—Amino acids other than alpha- or beta amino acids, e.g. gamma amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P41/00—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P41/00—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
    • C12P41/003—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions
    • C12P41/005—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions by esterification of carboxylic acid groups in the enantiomers or the inverse reaction
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/582—Recycling of unreacted starting or intermediate materials

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pyrrole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Préparation de gamma-aminoacides ayant une affinité pour la protéine alpha-2-delta II est décrit des matières et procédés pour la préparation de (gamma)-aminoacides optiquement actifs de formule (I), qui se lient à la sous-unité alpha-2-delta((alfa)2(delta)) d'un canal calcium.
MA31065A 2005-12-21 2008-06-20 Preparation de gamma-aminoacides ayant une affinite pour la proteine alpha-2-delta. MA30139B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US75283905P 2005-12-21 2005-12-21

Publications (1)

Publication Number Publication Date
MA30139B1 true MA30139B1 (fr) 2009-01-02

Family

ID=37903526

Family Applications (1)

Application Number Title Priority Date Filing Date
MA31065A MA30139B1 (fr) 2005-12-21 2008-06-20 Preparation de gamma-aminoacides ayant une affinite pour la proteine alpha-2-delta.

Country Status (28)

Country Link
US (2) US20070141684A1 (fr)
EP (2) EP2017259A3 (fr)
JP (1) JP2009520492A (fr)
KR (1) KR20080068932A (fr)
CN (1) CN101341117A (fr)
AP (1) AP2008004485A0 (fr)
AR (1) AR058559A1 (fr)
AU (1) AU2006327872A1 (fr)
BR (1) BRPI0620467A2 (fr)
CA (1) CA2633358A1 (fr)
CR (1) CR10080A (fr)
DO (1) DOP2006000286A (fr)
EA (1) EA200801393A1 (fr)
EC (1) ECSP088551A (fr)
GT (1) GT200600524A (fr)
IL (1) IL191840A0 (fr)
MA (1) MA30139B1 (fr)
ME (1) ME00005B (fr)
NL (1) NL2000374C2 (fr)
NO (1) NO20082989L (fr)
NZ (1) NZ568971A (fr)
PE (1) PE20071169A1 (fr)
RS (1) RS20080279A (fr)
TN (1) TNSN08272A1 (fr)
TW (1) TW200736201A (fr)
UY (1) UY30031A1 (fr)
WO (1) WO2007072159A1 (fr)
ZA (1) ZA200804780B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009141362A2 (fr) * 2008-05-21 2009-11-26 Sandoz Ag Procédé pour l'hydrolyse enzymatique stéréosélective d'un ester d'acide 5-méthyl-3-nitrométhyl-hexanoïque
BR112012029647A2 (pt) 2010-05-21 2016-08-02 Chemilia Ab novos derivados de pirimidinas
FR2966734B1 (fr) * 2010-10-29 2014-07-18 Max Rombi Composition comprenant au moins une enzyme proteolytique pour son utilisation pour empecher la synthese des triglycerides
RU2013147417A (ru) 2011-03-24 2015-04-27 Кемилиа Аб Новые производные пиримидина
CN102249833B (zh) * 2011-05-27 2013-12-11 中国科学院化学研究所 一种制备手性γ-氨基酸及其衍生物的方法
WO2017155025A1 (fr) * 2016-03-10 2017-09-14 第一三共株式会社 Procédé de production de dérivés optiquement actifs de l'acide valérique par résolution optique au moyen d'une enzyme
CN108192932B (zh) * 2017-12-26 2020-09-29 上海皓元生物医药科技有限公司 一种手性醇的酶催化制备方法
CN112877219A (zh) * 2021-01-29 2021-06-01 江西科技师范大学 一种高浓度胆固醇培养基及其制备方法和应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR0166088B1 (ko) 1990-01-23 1999-01-15 . 수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도
US5376645A (en) 1990-01-23 1994-12-27 University Of Kansas Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof
US5618710A (en) 1990-08-03 1997-04-08 Vertex Pharmaceuticals, Inc. Crosslinked enzyme crystals
GB9518953D0 (en) 1995-09-15 1995-11-15 Pfizer Ltd Pharmaceutical formulations
WO2000035298A1 (fr) 1996-11-27 2000-06-22 Wm. Wrigley Jr. Company Chewing-gum contenant des agents medicamenteux actifs
GB9711643D0 (en) 1997-06-05 1997-07-30 Janssen Pharmaceutica Nv Glass thermoplastic systems
US6642398B2 (en) * 1999-06-10 2003-11-04 Warner-Lambert Company Mono-and disubstituted 3-propyl gamma-aminobutyric acids
OA11962A (en) * 1999-06-10 2006-04-17 Warner Lambert Co Mono-and disubstituted 3-propyl gamma-aminobutyricacids.
WO2004054566A1 (fr) 2002-12-13 2004-07-01 Warner-Lambert Company Llc Derives de pregabalin pour le traitement de la fibromyalgie et d'autres troubles
UA82292C2 (uk) * 2004-04-14 2008-03-25 Пфайзер Продактс Инк. Спосіб стереоселективного біоперетворення аліфатичних динітрилів в ціанокарбонові кислоти (варіанти)

Also Published As

Publication number Publication date
JP2009520492A (ja) 2009-05-28
NL2000374A1 (nl) 2007-06-25
MEP0708A (xx) 2010-02-10
UY30031A1 (es) 2007-07-31
EP2017259A3 (fr) 2011-04-13
IL191840A0 (en) 2008-12-29
NO20082989L (no) 2008-09-19
PE20071169A1 (es) 2007-11-30
AU2006327872A1 (en) 2007-06-28
AP2008004485A0 (en) 2008-06-30
EP2017259A2 (fr) 2009-01-21
TNSN08272A1 (fr) 2009-10-30
ECSP088551A (es) 2008-07-30
RS20080279A (en) 2009-07-15
EP1973867A1 (fr) 2008-10-01
CN101341117A (zh) 2009-01-07
CA2633358A1 (fr) 2007-06-28
WO2007072159B1 (fr) 2008-08-21
EA200801393A1 (ru) 2009-12-30
WO2007072159A1 (fr) 2007-06-28
TW200736201A (en) 2007-10-01
CR10080A (es) 2008-07-10
US20070141684A1 (en) 2007-06-21
AR058559A1 (es) 2008-02-13
DOP2006000286A (es) 2007-07-31
GT200600524A (es) 2007-12-03
NZ568971A (en) 2010-04-30
ZA200804780B (en) 2009-05-27
BRPI0620467A2 (pt) 2011-11-16
NL2000374C2 (nl) 2010-02-09
KR20080068932A (ko) 2008-07-24
US20090299093A1 (en) 2009-12-03
ME00005B (fr) 2010-06-10

Similar Documents

Publication Publication Date Title
MA30139B1 (fr) Preparation de gamma-aminoacides ayant une affinite pour la proteine alpha-2-delta.
MA31606B1 (fr) Anticorps anti-cd 79b immunoconjugues et procedes d'utilisation
TNSN06210A1 (fr) Nitro-oxydérivés de prostaglandines
ATE284690T1 (de) Antithrombotische diamine
MA27658A1 (fr) Ethers de phenoxy d'acide amine
NO20043245L (no) Bindingsproteiner som biosensorer
EA200301213A1 (ru) Лиганды рецепторов 5-ht и их применение
EA200802170A1 (ru) Лиофилизированная композиция терапевтического пептидного антитела
SV2003001103A (es) Formulaciones autoemulsionantes de inhibidores de la proteina de transferencia de colesteril ester pc10894
MA31502B1 (fr) Anticorps anti-notch 1 specifiques a nrr et ses procedes d'utilisation
BRPI0413449A (pt) compostos de quinoxalina
EA200900613A1 (ru) Спирокетоновые ингибиторы ацетил-коа-карбоксилаз
RS54133B1 (en) ANTI-IL-6 ANTIBODIES, PREPARATIONS, PREPARATION AND USE PROCEDURES
WO2004024097A8 (fr) Compositions et methodes de traitement de maladies de nature immune
PT1474425E (pt) Desazapurinas e sua utilizacao
EA200401127A1 (ru) АМИНОКИСЛОТЫ С АФФИННОСТЬЮ К α2δ-БЕЛКУ
BR0314666A (pt) Composição nutricional ou terapêutica utilizável para o tratamento de mamìferos para aumentar a atividade imune e método de tratar um mamìfero para aumentar a concentração de glutationa no tecido no referido mamìfero
MA27412A1 (fr) Nouveaux pyrimidine-4,6-dicarboxamides pour l'inhibition selective de collagenases
UY27618A1 (es) Ésteres hidroxamato de ácido n-(4-fenil-sustituido)-antranílico
UY27632A1 (es) Metabolitos del ácido (3-((4- terc- butilbencil)-piridin.3- sulfonil) amino) metil ) fenoxi) acético
BR0315864A (pt) Composições e processos para a modificação efeitos tóxicos de compostos proteináceos
EA200600404A1 (ru) Пероральные препаративные формы кладрибина
ITMI20022394A1 (it) Uso di triiodotironina 3-solfato come farmaco ad attivita' tireomimetica e relative formulazioni farmaceutiche.
TR200200494T2 (tr) Yağlı asit sintazı inhibitörleri.
TW200505906A (en) Selective mmp-13 inhibitors